R4 Ballot #1 (Mixed Normative/Trial use)

This page is part of the FHIR Specification (v3.3.0: R4 Ballot 2). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4B R4 R3

Codesystem-adverse-event-causality-assess.json

Patient Care Work GroupMaturity Level: N/ABallot Status: Informative

Raw JSON (canonical form)

Definition for Code System AdverseEventCausalityAssessment

{
  "resourceType": "CodeSystem",
  "id": "adverse-event-causality-assess",
  "meta": {
    "lastUpdated": "2018-04-03T12:05:46.262+10:00"
  },
  "text": {
    "status": "generated",
    "div": "<div>!-- Snipped for Brevity --></div>"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
      "valueCode": "pc"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-ballot-status",
      "valueString": "Draft"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
      "valueInteger": 1
    }
  ],
  "url": "http://hl7.org/fhir/adverse-event-causality-assess",
  "identifier": {
    "system": "urn:ietf:rfc:3986",
    "value": "urn:oid:2.16.840.1.113883.4.642.1.841"
  },
  "version": "3.3.0",
  "name": "AdverseEventCausalityAssessment",
  "status": "draft",
  "experimental": false,
  "date": "2018-04-03T12:05:46+10:00",
  "publisher": "HL7 (FHIR Project)",
  "contact": [
    {
      "telecom": [
        {
          "system": "url",
          "value": "http://hl7.org/fhir"
        },
        {
          "system": "email",
          "value": "fhir@lists.hl7.org"
        }
      ]
    }
  ],
  "description": "TODO",
  "caseSensitive": true,
  "valueSet": "http://hl7.org/fhir/ValueSet/adverse-event-causality-assess",
  "content": "complete",
  "concept": [
    {
      "code": "Certain",
      "display": "Certain",
      "definition": "i) Event or laboratory test abnormality, with plausible time relationship to drug intake ii) Cannot be explained by disease or other drugs iii) Response to withdrawal plausible (pharmacologically, pathologically) iv) Event definitive pharmacologically or phenomenologically (i.e. an objective and specific medical disorder or a recognized pharmacological phenomenon) v) Re-challenge satisfactory, if necessary"
    },
    {
      "code": "Probably-Likely",
      "display": "Probably/Likely",
      "definition": "i) Event or laboratory test abnormality, with reasonable time relationship to drug intake ii) Unlikely to be attributed to disease or other drugs iii) Response to withdrawal clinically reasonable iv) Re-challenge not required"
    },
    {
      "code": "Possible",
      "display": "Possible",
      "definition": "i) Event or laboratory test abnormality, with reasonable time relationship to drug intake ii) Could also be explained by disease or other drugs iii) Information on drug withdrawal may be lacking or unclear"
    },
    {
      "code": "Unlikely",
      "display": "Unlikely",
      "definition": "i) Event or laboratory test abnormality, with a time to drug intake that makes a relationship improbable (but not impossible) ii) Disease or other drugs provide plausible explanations"
    },
    {
      "code": "Conditional-Classified",
      "display": "Conditional/Classified",
      "definition": "i) Event or laboratory test abnormality ii) More data for proper assessment needed, or iii) Additional data under examination"
    },
    {
      "code": "Unassessable-Unclassifiable",
      "display": "Unassessable/Unclassifiable",
      "definition": "i) Report suggesting an adverse reaction ii) Cannot be judged because information is insufficient or contradictory iii) Data cannot be supplemented or verified"
    }
  ]
}

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.